The store will not work correctly when cookies are disabled.
4-(N,5-Dimethyl-3-phenylisoxazole-4-carboxamido)benzoic acid
ID: ALA4556312
PubChem CID: 155557146
Max Phase: Preclinical
Molecular Formula: C19H16N2O4
Molecular Weight: 336.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1onc(-c2ccccc2)c1C(=O)N(C)c1ccc(C(=O)O)cc1
Standard InChI: InChI=1S/C19H16N2O4/c1-12-16(17(20-25-12)13-6-4-3-5-7-13)18(22)21(2)15-10-8-14(9-11-15)19(23)24/h3-11H,1-2H3,(H,23,24)
Standard InChI Key: YRGFNUKTVBILLW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.5009 -20.9746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9137 -21.6847 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7166 -21.5121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8037 -20.6945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0502 -20.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5102 -20.2838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5077 -19.4666 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2191 -20.6902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8763 -19.5689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4835 -19.0204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3115 -18.2223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5328 -17.9716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9260 -18.5252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1011 -19.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3241 -22.0587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9256 -20.2794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6330 -20.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3389 -20.2775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3369 -19.4594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6229 -19.0532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9199 -19.4656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2217 -21.5074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0428 -19.0477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7523 -19.4532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0392 -18.2305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
4 6 1 0
6 7 2 0
6 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
5 9 1 0
3 15 1 0
8 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 22 1 0
19 23 1 0
23 24 1 0
23 25 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.35 | Molecular Weight (Monoisotopic): 336.1110 | AlogP: 3.62 | #Rotatable Bonds: 4 |
Polar Surface Area: 83.64 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.14 | CX Basic pKa: ┄ | CX LogP: 3.18 | CX LogD: 0.11 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -1.33 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |